Bettina K. Andreassen

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Risk of recurrence of stage I to III melanoma in Norway, 2008-2022.

Risk of recurrence of stage I to III melanoma in Norway, 2008-2022.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 29, 2026

Translating CLEOPATRA into routine practice: National treatment patterns and survival for patients with HER2-positive metastatic breast cancer.

Translating CLEOPATRA into routine practice: National treatment patterns and survival for patients with HER2-positive metastatic breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: January 10, 2026

Tumor cell invasion in blood vessels but not lymphatic vessels in TURBT predicts poor prognosis in bladder cancer.

Tumor cell invasion in blood vessels but not lymphatic vessels in TURBT predicts poor prognosis in bladder cancer.

Journal: Urologic oncology

Published: November 26, 2025

Real-world outcomes of immunotherapy in advanced NSCLC patients with comorbidities.

Real-world outcomes of immunotherapy in advanced NSCLC patients with comorbidities.

Journal: British journal of cancer

Published: November 11, 2025

Anti-HER2 treatment in everyday practice: how we treat older women with breast cancer differently.

Anti-HER2 treatment in everyday practice: how we treat older women with breast cancer differently.

Journal: Breast cancer research and treatment

Published: November 03, 2025

Aprepitant use during chemotherapy and association with survival in women with early breast cancer.

Aprepitant use during chemotherapy and association with survival in women with early breast cancer.

Journal: Journal of the National Cancer Institute

Published: February 18, 2025

Anti-Her2 therapy patterns in metastatic breast cancer-Real-world data suggest undertreatment.

Anti-Her2 therapy patterns in metastatic breast cancer-Real-world data suggest undertreatment.

Journal: International journal of cancer

Published: January 20, 2025

Postoperative Treatment and Survival in Locally Advanced Prostate Cancer: Real-World Outcomes.

Postoperative Treatment and Survival in Locally Advanced Prostate Cancer: Real-World Outcomes.

Journal: Clinical genitourinary cancer

Published: December 04, 2024

Immortal time bias in survival outcomes when comparing treatment with chemotherapy versus immunochemotherapy for non-small cell lung cancer.

Immortal time bias in survival outcomes when comparing treatment with chemotherapy versus immunochemotherapy for non-small cell lung cancer.

Journal: Translational lung cancer research

Published: October 24, 2024

Let's talk about sex: Survival among females and males in a real-world cohort treated with pembrolizumab for non-small cell lung cancer.

Let's talk about sex: Survival among females and males in a real-world cohort treated with pembrolizumab for non-small cell lung cancer.

Journal: International journal of cancer

Published: October 09, 2024

Detection and agreement of blood- and lymph vessel invasion assessed by immunohistochemistry in matched TURBT and radical cystectomy specimens.

Detection and agreement of blood- and lymph vessel invasion assessed by immunohistochemistry in matched TURBT and radical cystectomy specimens.

Journal: Pathology, research and practice

Published: September 18, 2024

Time trends in systemic treatment for patients with metastatic prostate cancer: a national cohort study.

Time trends in systemic treatment for patients with metastatic prostate cancer: a national cohort study.

Journal: Acta oncologica (Stockholm, Sweden)

Published: September 19, 2023

Showing 1-12 of 60

Last Updated: 09/26/2026